2 killed in Dr Reddy's nitrogen gas leak

Image
BS Reporter Hyderabad
Last Updated : Jan 20 2013 | 1:37 AM IST

Don't want to miss the best from Business Standard?

Two persons died after inhaling poisonous gas at a manufacturing facility belonging to city-based pharmaceutical major Dr Reddy’s Laboratories. The incident took place on Tuesday night at the company’s Unit-III, which was set up recently at Bollaram in Medak district of Andhra Pradesh.

The deceased have been identified as Chiranjeevi Sridhar Reddy (38), a production chemist, and Deepak Jena (22), a contract labourer from Orissa. Both of them were on night duty. The police have registered a case and are carrying out investigations.

The Bollaram facility is a US Food & Drug Administration-approved plant and produces active pharmaceutical ingredients. It makes several products, including Omeprazole used in the treatment of peptic ulcer.

The production of drugs and other products at the plant has not been affected due to the gas leak, a company official said.

According to initial information, the leak was of nitrogen gas. The plant suffered a power outage at the time and the leaked gas could not be pumped out. The two affected persons were rushed to a nearby hospital, but the doctors declared them “brought dead”.

“We are gathering information about the accident. The cause of death is not known yet,” said Jagadish, a sub-inspector at Bollaram police station. This was the first accident at Unit-III.

At the time of the accident, Dr Reddy’s stated in a press release, the deceased were engaged in micronisation of Omeprazole powder. No one else was affected.

According to the company, the incident took place in the clean room located in one of the production blocks. Access to that area has been restricted.

“Investigations by multiple authorities, including the Factories Inspectorate, the Drugs Control Administration, Hyderabad, and the police, are in progress and we will share full details once the investigations are concluded,” the company stated. It expressed condolences to the families of the victims.

The company is likely to announce compensation for the kin of the deceased based on the investigation reports and its own assessment of the cause of death. It will also conduct its own probe.

Dr Reddy’s stock ended the day at Rs 1,677.4, down 0.61 per cent from the previous close of Rs 1,687.75 on the BSE. During the day, it touched a low of Rs 1,618 and a high of Rs 1,710.4.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 23 2010 | 12:07 AM IST

Next Story